Lv5
1412 积分 2023-07-25 加入
Trends in the approval of cancer therapies by the FDA in the twenty-first century
14天前
已完结
Quantitative imaging of dynamic processes in intestinal organoids
1个月前
已完结
Advancing therapeutics in small-cell lung cancer
4个月前
已完结
New promises and challenges in the treatment of advanced non-small-cell lung cancer
4个月前
已完结
Evolution of systemic therapy for stages I–III non-metastatic non-small-cell lung cancer
4个月前
已完结
The changing treatment landscape of EGFR-mutant non-small-cell lung cancer
4个月前
已完结
Navigating the landscape of EGFR TKI resistance in EGFR-mutant NSCLC — mechanisms and evolving treatment approaches
4个月前
已完结
The non-small-cell lung cancer drug market
4个月前
已完结
The small-cell lung cancer drug market
4个月前
已完结
Patient-Derived Ovarian Cancer Organoids as Platforms for Predicting Platinum Resistance and Screening Tumor Stem Cell Inhibitors
5个月前
已关闭
皖公网安备34019202002308
